Epoetin alfa in critically ill patients.
作者信息
van der Putten Karien, Braam Branko, Gaillard Carlo A
出版信息
N Engl J Med. 2007 Dec 13;357(24):2515-6; author reply 2516-7.
PMID:18084815
Abstract
摘要
相似文献
1
Epoetin alfa in critically ill patients.
N Engl J Med. 2007 Dec 13;357(24):2515-6; author reply 2516-7.
2
Blood conservation in the critically ill.
Am J Health Syst Pharm. 2007 Aug 15;64(16 Suppl 11):S11-8. doi: 10.2146/ajhp070245.
3
Is there a place for epoetin alfa in managing anemia during critical illness?
Clin Ther. 2004 Jun;26(6):819-29. doi: 10.1016/s0149-2918(04)90126-9.
4
Targeting anemia with erythropoietin during critical illness.
N Engl J Med. 2007 Sep 6;357(10):1037-9. doi: 10.1056/NEJMe078150.
5
Epoetin alfa in critically ill patients.
N Engl J Med. 2007 Dec 13;357(24):2516; author reply 2516-7.
6
Erythropoietic agents for anemia of critical illness.
Am J Health Syst Pharm. 2008 Mar 15;65(6):540-6. doi: 10.2146/ajhp070225.
7
Anemia in the critically ill: the role of erythropoietin.
Semin Hematol. 2001 Jul;38(3 Suppl 7):24-32. doi: 10.1016/s0037-1963(01)90127-1.
8
Epoetin alfa protocol and multidisciplinary blood-conservation program for critically ill patients.
Am J Health Syst Pharm. 2005 Feb 15;62(4):400-5. doi: 10.1093/ajhp/62.4.0400.
9
Pharmacokinetics and pharmacodynamics of once-weekly subcutaneous epoetin alfa in critically ill patients: results of a randomized, double-blind, placebo-controlled trial.
Crit Care Med. 2006 Jun;34(6):1661-7. doi: 10.1097/01.CCM.0000217919.22155.85.
10
Use of epoetin.
Hematol J. 2003;4(1):85; author reply 86. doi: 10.1038/sj.thj.6200204.
Zotero 插件